drugset / Trial / NCT00000879

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers

NCT00000879 ↗

Double-blindPrevention

Summary

The purpose of this study is to see if giving the ALVAC vCP1452 anti-HIV vaccine alone or with another vaccine called AIDSVAX B/B to babies of HIV-positive mothers is safe. The study will also look at how these vaccines affect a baby's immune system. Most HIV-positive children get HIV from their mothers during pregnancy or birth. Treatment with anti-HIV drugs can reduce the baby's risk of getting HIV. Vaccines also may help prevent HIV infection. This study will look at whether the ALVAC vCP1452 vaccine and the AIDSVAX B/B vaccine can help the body fight off HIV infection. There is no chance of getting HIV infection from the vaccines. (This study has been changed. In earlier versions, ALVAC vCP205 and AIDSVAX B/E were going to be used.)

Timeline

Start
—
Primary completion
—
Completion
2005-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ALVAC(2)120(B,MN)GNP Vaccine — —
Subject ALVAC-HIV MN120TMG Vaccine — —
Subject MN rsgp120/HIV-1 Vaccine — —